Extended Release Buprenorphine

DRUG2 trials

Sponsors

Gavin Bart, University of Texas Southwestern Medical Center

Conditions

Cocaine Use DisorderOpioid Use Disorder, ModerateOpioid Use Disorder, SevereSubstance Use Disorder

Phase 2

EXHIT ENTRE Comparative Effectiveness Trial

CompletedNCT04345718

Gavin BartOpioid Use Disorder, Moderate, Opioid Use Disorder, Severe, Substance Use Disorder

Start: 2021-08-09End: 2025-08-27Updated: 2025-12-09

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

CompletedNCT05262270

University of Texas Southwestern Medical CenterCocaine Use Disorder

Start: 2023-04-18End: 2025-07-21Updated: 2025-10-21

Related Papers

Randomized, placebo-controlled trial of injectable extended-release naltrexone and injectable extended-release buprenorphine for cocaine use disorder (CURB-2): Study rationale and design.

2025-05-11

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder.

2024-12-02

Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population.

2023-09-195 citations